The key event for the pharmaceutical industry, the 27th annual RUSSIAN PHARMACEUTICAL FORUM 2021 will take place on 12-13 May 2021 at our traditional venue, the Corinthia Hotel in SAINT PETERSBURG, as well as in live ONLINE format.
Join us at this meeting of the key international and Russian pharmaceutical industry experts!
Meet new partners and network with the leading players on the pharmaceutical market – both in person in SAINT PETERSBURG (places strictly limited!), or via our online event platform, using live online chat, emails and video calls!
If you are unable to join us in-person in St. Petersburg, you can connect to the event from your laptop, tablet or mobile phone – so you can save time travelling and maximise time learning from experts and engaging with speakers and other delegates.
Head of Federal State Center For Planning And Organization Of Drug Supply
Ministry of Health of Russian Federation (Online)
Head, Division for Coordination of Common Market for Drugs and Medical Devices Formation
Eurasian Economic Commission
Director
Federal State Institution "State Institute of Drugs and Good Practices" of the Ministry of Industry and Trade of the Russian Federation
State Duma Deputy
Russian State Duma (Online)
Head of 'Pharma Group'
CRPT
Head of Department for Provision of State Services
Federal Service for Intellectual Property (Rospatent)
President
Takeda
Managing Director, Russia & CIS
Johnson & Johnson
Executive Vice President, Russia and CIS
STADA
General Director, Eurasia
Sanofi
General Director
R-Pharm
Managing Director, Russia and CIS
Merck
General Manager
Geropharm
President
Nanolek
Chief Cardiologist
Ministry of Defense of the Russian Federation
General Director
Protek
General Director
NovaMedica
General Director
Pharmacy Chain 36.6
President
Active Component JSC
Chairman of the Expert Board
Institute of Public Healthcare Development
Market Access, Pricing and Commercial Director, Russia & CIS
Merck
First Deputy General Manager
Nanolek
Vice President, R&D
NovaMedica
Executive Director
AIPM Russia
General Director
Association of Russian Pharmaceutical Manufacturers
GA&P Senior Director Russia & CIS
Johnson & Johnson
General Director
R&D Centre NovaMedica Innotech
Executive Director
Association of Pharmaceutical Companies “Innovative Pharma”
Deputy General Director, Chief Investment and Digital Officer
Nanolek
Deputy General Director, Legal Affairs & Governmental Relations
Nanolek
Medical Director
Ipsen
Head of Consumer Healthcare
Ipsen
Supply Chain Manager
Merck Biopharma Russia & CIS
Senior Manager, Strategic Marketing Life Sciences EMEA
Sensitech
Senior Director, Corporate Affairs, Health & Value and Communications
Pfizer Russia & Belarus
Market Access Director
Pfizer Russia & Belarus
Rare Disease BU Lead
Pfizer Russia & Belarus
Market Access and Public Affairs Director, Russia & CIS
Ipsen
Commercial Director, Russia and CIS
STADA
General Manager
Eurasian Centre for Integrational Research and Communication
General Manager
LifeScan
General Director
Proapteka
Commercial Director
CV Protek
Executive Director
Russian Association of Pharmacy Chains
Director
Association of Indepedent Pharmacies
Founder, Managing Partner
RBV Capital
General Director
Group of Companies ASNA
Eyecare Department Managing Director
Alcon Russia
Project Manager, vseapteki.ru
Mail.Ru Group
Managing Director
GDP
Quality & Compliance Senior Manager, Russia, Ukraine, Central & Eastern Europe
Johnson & Johnson
Market Access Director, Russia and Eurasia
AstraZeneca
Vice President, Biomedical Cluster
Skolkovo
General Director
Rigla (Online)
Senior Director Regulatory Affairs & Healthcare Policy
AIPM Russia
Head of the Department of Chemistry, Biotechnology and Medicine
Federal Institute of Industrial Property
Key Account Director
Teva
Director Government Affairs & Market Access, Russia and Eurasia
Teva
Quality Director, Russia and Eurasia
Teva
Executive Director of Medical Affairs
Takeda Russia
Corporate Affairs and Legal Director
AstraZeneca Russia & Eurasia
HR Director
STADA Russia and CIS
HR Director of R&D Center
Novamedica Innotech
Digitalisation Director Russia and Eurasia
Teva
Independent Expert
Market Access Director
Takeda
Industrial Policy Director
AIPM
Director of GR projects
Yandex.market
Commercial Director
Pharmacy Chain 36.6
Government Affairs Director
Geropharm
Deputy General Commercial Manager
GDP
HR Director
Geropharm
Strategic Marketing Director
Geropharm
Regional Director
Stada CIS (Online)
Country Principal, Russia & CIS
IQVIA
Associate Operations / Resources Director
IQVIA
President
All-Russian Public Organisation 'Patient Protection League'
Director of Healthcare Economics
R-Pharm
Head of Legal Services to Pharmaceutical Companies
PwC Legal
Director, Pharmaceutical and Medico-Biological Companies Services Practice
PwC
General Director
DSM Group
Government and External Relations Director
Santens Group of Companies
Managing Partner
Breffi
CEO
ADV Lab & Benchmark
Co-Chair
Russian Patients Association
Technology Principal
IQVIA
Commercial Director
Navicon
Director
Institute of Competitive Technologies
General Manager
Sanofi Pasteur
Head of Development and External Affairs Department
The Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation (Online)
Director
Pulse Pharmaceutical Company
Chief Digital Officer, Russia and Eurasia
Sanofi
Director, MA & Pricing Department
Bristol Myers Squibb
General Manager
Proxima Research Russia
Chief Editor
Pharmvestnik
Multi-channel and Trade Marketing Director
Proxima Research in Russia
Co-President
Russian Diabetic Federation
Managing Director
Ipsos Healthcare (Online)
Head, Specialized Medicines Division
Nanolek
General Director
Generium
Marketing Director
SBER EAPTEKA
Head of Communications & Government Affairs, Russia, MENA / CIS
GSK
President
National Association of Rare Disease Organisations 'Genetica'
Co-Founder and General Partner
ATEM Capital
Executive Director
The Union of Professional Pharmaceutical Organizations (SPFO)
Executive Director
Katren
Director of Clinical Research & Medical Affairs
AIPM Russia
Director of Development
Katren
Legal and IP Director
AIPM Russia
Business Ethics Director
Takeda
Market Access Head Russia and CIS
CSL Behring
Head of PR and Government Affairs
Roche
Responsible Secretary, Expert Committee on Drug Regulation, Pharmaceutical and Medical Industry Development
Russian State Duma Healthcare Committee
Head of Disctribution and Tender Channel
GSK Pharma
HR Director
Sandoz Russia
General Director
AlphaRM
Director
Institute for Translational Medicine and Biotechnology, Sechenov First Moscow State Medical University of the Russian Ministry of Health
Director
“Genome” Patient Support Centre
Medical Director
Sandoz (Online)
Legal and Compliance Specialist
AIPM
Head of Department for Specialized Medical Care
Department of Healthcare of the Khanty-Mansiysk Autonomous Region
First Deputy Chairman
Health Committee of St. Petersburg
Deputy Dean for Innovation, Faculty of Biology
Lomonosov Moscow State University*
Head of Rare Diseases and Multiple Sclerosis Units
Sanofi*
President
Association of Oncology Patients “Zdravstvuy!”
Deputy General Director for Organizational and Methodical Work and Interaction with Regions of the Russian Federation
National Medical Research Center for Haematology
Head of Trade Marketing
Yandex.Market
E-Commerce Lead
Bayer
Director
Children's Research and Clinical Center for Infectious Diseases (of the Federal Medical and Biological Agency)
Reviewer "Career & HR"
Pharmvestnik
Deputy Director for Educational Activities
N. N. Blokhin Russian Cancer Research Center
Oncologist
Association of Oncology Patients "Zdravstvuy!"
Chairman of the Board
"House of Patients with Orphan Diseases" (Online)
Chief Freelance Specialist Clinical Pharmacologist
Moscow Department of Health
Interview with Alexey Savin – Regional Principal, Eastern Europe, Russia & CIS – IQVIA
The Russian Pharma Forum is an annual meeting place, the main platform for active and productive dialogue between all the principal stakeholders in the Russian pharmaceutical market. What questions will be discussed in 2021?
REGULATION OF THE SECTOR
Pharma versus coronavirus: interviews with General Directors
General Directors of the leading companies on the market have discussed with the Russian Pharmaceutical Forum the main challenges they are facing during the pandemic, and possible approaches to collaborating with the government on developing both a vaccine and treatments for COVID-19.
The SARS-CoV-2 coronavirus pandemic has kicked the rate of development in the pharmaceutical industry into a new gear. At the early stages of the epidemic in Russia, the demand for medical masks, antiseptics and antivirals soared. A series of regulatory decisions followed, taken at an unprecedented speed, outlining a new set of rules for maximum retail prices and distance selling of medical products.
The pharmaceutical industry is undergoing enormous change fuelled by a global crisis in healthcare. But pharma also has a key role to play in the search for ways out of the current situation.
The most important pharmaceutical conference in Russia! Excellent opportunity to meet your key partners in one place
Abbott Laboratories
AbbVie
Alfa Wassermann
Allergan
Almirall
Amgen
Angelini Francesco
Baxter
Bayer Pharma
Belupo
Berlin-Chemie
Besins Healthcare
Biogen Interntional
Bittner Pharma
Boehringer Ingelheim
Boiron
Bosnalijek
Bristol-Myers Squibb
EGIS
Eisai
Eli Lilly Vostok
Galderma
Glenmark Pharmaceuticals
Hikma Pharmaceuticals
Ipsen
KRKA Pharma
Lupin
Merck
Nanolek
Novo Nordisk
Petrovax Pharm
Ranbaxy
Reckitt Benckiser
Roche
Servier
Shreya Life Sciences
27 years in the market! Russia's longest-running pharmaceutical forum
The highest profile executive-level speakers and attendees
Unrivalled networking opportunities - meet key decision makers